Recently, our group has demonstrated that IL-17 promotes polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) mediated immunosuppression in human CRC progression (unpublished data). This evidence concerns the gene IL17A and colorectal carcinoma.